Amneal director exercises options for 20K shares
A director of Amneal Pharmaceuticals exercised vested stock options to acquire additional Class A Common Stock and now holds shares both directly and through a trust.
Rhea-AI Filing Summary
Amneal Pharmaceuticals, Inc. (AMRX) director Kevin J. Buchi exercised options on September 11, 2026 to acquire 20,445 shares of Class A Common Stock at an exercise price of $14.45 per share, eliminating this option position. Following the transaction, he holds 95,522 shares directly and 93,499 shares indirectly through a trust. The exercised option was fully vested and currently exercisable, and no Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
20,445 shares exercised/converted
Exercise
3 txns
Insider
BUCHI J KEVIN
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1 | 20,445 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 20,445 | $14.45 | $295K |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option — 0 contracts (Direct);
Class A Common Stock — 95,522 shares (Direct);
Class A Common Stock — 93,499 shares (Indirect, By Trust)
Footnotes (1)
- F1. The option is vested and currently exercisable.
Key Figures
Options exercised: 20,445 shares
Exercise price: $14.45 per share
Direct holdings after transaction: 95,522 shares
+2 more
5 metrics
Options exercised
20,445 shares
Stock options exercised by director on September 11, 2026
Exercise price
$14.45 per share
Exercise price for 20,445 options converted into Class A Common Stock
Direct holdings after transaction
95,522 shares
Director’s direct Class A Common Stock position after September 11, 2026 exercise
Indirect holdings by trust
93,499 shares
Class A Common Stock held indirectly by trust for the director
Options exercised shares underlying
20,445 shares
Underlying Class A Common Stock for the exercised option position
Key Terms
Stock Option, Class A Common Stock, indirect ownership, By Trust
4 terms
Stock Option financial
"A Stock Option was exercised to acquire Class A Common Stock."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Class A Common Stock financial
"The transactions involve shares of Class A Common Stock."
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
indirect ownership financial
"Indirect ownership of shares is reported as held by trust."
By Trust financial
"An indirect holding is described as held By Trust."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Amneal Pharmaceuticals (AMRX) director Kevin J. Buchi do in this Form 4?
He exercised stock options on September 11, 2026 to acquire 20,445 shares of Amneal Pharmaceuticals Class A Common Stock at an exercise price of $14.45 per share, eliminating that particular option position and increasing his direct share ownership.
What are Kevin J. Buchi’s direct holdings in AMRX after the reported transactions?
After the reported transactions, Kevin J. Buchi directly holds 95,522 shares of Amneal Pharmaceuticals Class A Common Stock, as of September 11, 2026.
What are the indirect holdings reported for the Amneal Pharmaceuticals (AMRX) director?
In addition to his direct holdings, an indirect position of 93,499 shares of Amneal Pharmaceuticals Class A Common Stock is reported for Kevin J. Buchi, held by trust.
Were the exercised Amneal Pharmaceuticals (AMRX) options already vested?
Yes. A footnote states that the option is vested and currently exercisable, meaning the 20,445 options exercised on September 11, 2026 were fully vested at the time of exercise.
Was the Amneal Pharmaceuticals (AMRX) director’s transaction under a Rule 10b5-1 trading plan?
No. The report indicates no Rule 10b5-1 trading plan for these transactions, so the option exercise on September 11, 2026 is not described as occurring under such a pre-arranged plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
